Avista Capital Partners in partnership with Dana Holdings announced the completion of its acquisition of Kramer Laboratories, a marketer of over-the-counter foot care and specialty cough products.    Kramer’s portfolio includes leading foot care brands such as The Original Fungi-Nail Toe & Foot and HC Max, as well as the Safetussin, brand of specialty cough solutions.   David Burgstahler, president and co-managing partner of Avista, said, “We are excited to welcome Kramer to ...